Use of a specific antagonist of 5HT2 receptor antagonist for the preparation of medicines useful in the treatment of sleep apnoea syndrome
摘要
<p>Use of 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one-0-(2-dimethylami noethyl)oxime, or one of it's pharmaceutically acceptable salts, for the preparation of medicines in the treatment of sleep apnoea syndrome.</p>
